Tymlos 80 MCG dose pen injectr 1.56ML
Ended Awarded Last action
- Contract number
- SPE2DR26FCRM8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,245
Award facts
- Contract value 100% obligated
- $10,245.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $10,245.42 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of TYMLOS 80 MCG Dose Pen Injectr 1.56ML. This firm fixed-price delivery order, awarded on December 8, 2025, is due for completion by December 9, 2025, and carries no set-aside designation. The contract represents one of numerous delivery orders issued to DMS Pharmaceutical Group under its broader Indefinite Delivery Contract with the Defense Logistics Agency.
DMS Pharmaceutical Group's supply of TYMLOS operates under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion Department of Defense pharmaceutical acquisition strategy. DMS Pharmaceutical Group holds a single-award IDC with a $499.999 billion ceiling value extending through December 31, 2036, positioning the company as a critical supplier for pharmaceutical and medical consumable products supporting military healthcare facilities worldwide. The vendor's portfolio encompasses branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and related medical supplies, with delivery orders issued without competitive restrictions demonstrating the contractor's established capability to meet federal procurement standards.
Quick answers
Who was awarded contract SPE2DR26FCRM8?
SPE2DR26FCRM8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26FCRM8 worth?
The government has obligated $10,245 on SPE2DR26FCRM8.
Is contract SPE2DR26FCRM8 an order under another contract?
Yes. SPE2DR26FCRM8 is a delivery order under SPE2DR25D9168, an indefinite delivery contract.
Was contract SPE2DR26FCRM8 competed?
The extent of competition for SPE2DR26FCRM8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award